Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals EPS Diluted (Quarterly) : -1.355 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.355 |
| March 31, 2026 | -0.932 |
| December 31, 2025 | 0.219 |
| September 30, 2025 | -0.175 |
| June 30, 2025 | -1.260 |
| March 31, 2025 | 2.755 |
| December 31, 2024 | -1.386 |
| September 30, 2024 | -1.371 |
| June 30, 2024 | -1.375 |
| March 31, 2024 | -1.016 |
| December 31, 2023 | -1.237 |
| September 30, 2023 | -1.022 |
| June 30, 2023 | -0.9621 |
| March 31, 2023 | 0.4501 |
| December 31, 2022 | -0.3897 |
| September 30, 2022 | -0.807 |
| June 30, 2022 | -0.6813 |
| March 31, 2022 | 0.4111 |
| December 31, 2021 | -0.6014 |
| September 30, 2021 | -0.6075 |
| June 30, 2021 | -0.2875 |
| March 31, 2021 | -0.2582 |
| December 31, 2020 | -0.2018 |
| September 30, 2020 | -0.4731 |
| June 30, 2020 | -0.1336 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1951 |
| December 31, 2019 | -0.0275 |
| September 30, 2019 | 0.12 |
| June 30, 2019 | 0.2056 |
| March 31, 2019 | 0.2436 |
| December 31, 2018 | 0.1259 |
| September 30, 2018 | -0.1216 |
| June 30, 2018 | -0.18 |
| March 31, 2018 | -0.18 |
| December 31, 2017 | -0.18 |
| September 30, 2017 | -0.14 |
| June 30, 2017 | -0.07 |
| March 31, 2017 | -0.08 |
| December 31, 2016 | -0.17 |
| September 30, 2016 | -0.34 |
| June 30, 2016 | -0.32 |
| March 31, 2016 | -0.35 |
| December 31, 2015 | -0.32 |
| September 30, 2015 | -0.42 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.51 |
| December 31, 2014 | -0.41 |
| September 30, 2014 | -0.42 |
| June 30, 2014 | -0.22 |
| March 31, 2014 | -0.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -0.0464 |
| Moderna, Inc. | -1.965 |
| Revolution Medicines, Inc. | -3.055 |
| Intellia Therapeutics, Inc. | -0.7989 |
| Denali Therapeutics, Inc. | -0.681 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -178.92M |
| Revenue (Quarterly) | 75.25M |
| Total Expenses (Quarterly) | 269.53M |
| Enterprise Value | 8.834B |
| Gross Profit Margin (Quarterly) | 91.15% |
| Profit Margin (Quarterly) | -237.8% |
| Earnings Yield | -3.49% |
| Normalized Earnings Yield | -3.494 |